$60.10
0.48% today
NYSE, Apr 01, 06:17 pm CET
ISIN
US2074101013
Symbol
CNMD

Conmed Corp. Stock price

$60.39
+1.22 2.06% 1M
-11.53 16.03% 6M
-8.05 11.76% YTD
-18.58 23.53% 1Y
-88.16 59.35% 3Y
+3.12 5.45% 5Y
+9.90 19.61% 10Y
NYSE, Closing price Mon, Mar 31 2025
+1.54 2.62%
ISIN
US2074101013
Symbol
CNMD
Sector

Key metrics

Market capitalization $1.87b
Enterprise Value $2.79b
P/E (TTM) P/E ratio 14.20
EV/FCF (TTM) EV/FCF 18.13
EV/Sales (TTM) EV/Sales 2.14
P/S ratio (TTM) P/S ratio 1.43
P/B ratio (TTM) P/B ratio 1.94
Dividend yield 1.32%
Last dividend (FY24) $0.80
Revenue growth (TTM) Revenue growth 4.98%
Revenue (TTM) Revenue $1.30b
EBIT (operating result TTM) EBIT $172.07m
Free Cash Flow (TTM) Free Cash Flow $153.88m
Cash position $24.46m
EPS (TTM) EPS $4.25
P/E forward 14.46
P/S forward 1.38
EV/Sales forward 2.05
Short interest 12.57%
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Conmed Corp. forecast:

3x Buy
43%
4x Hold
57%

Analyst Opinions

7 Analysts have issued a Conmed Corp. forecast:

Buy
43%
Hold
57%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,303 1,303
5% 5%
100%
- Direct Costs 615 615
1% 1%
47%
688 688
9% 9%
53%
- Selling and Administrative Expenses 405 405
1% 1%
31%
- Research and Development Expense 54 54
3% 3%
4%
228 228
35% 35%
18%
- Depreciation and Amortization 56 56
0% 0%
4%
EBIT (Operating Income) EBIT 172 172
52% 52%
13%
Net Profit 132 132
105% 105%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025. “My fellow directors and I are extremely pleased to welcome Mark to the board,” said Martha Goldberg Aronson, Chair of CONMED's Board of Directors. “Mark brings a wealth of experience to CONMED, including deep knowledge across finance...
Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company'...
Neutral
Seeking Alpha
about 2 months ago
CONMED Corporation (NYSE:CNMD ) Q4 2024 Results Conference Call February 5, 2025 4:30 PM ET Company Participants Pat Beyer - Chief Executive Officer & President Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Robbie Marcus - JPMorgan Vik Chopra - Wells Fargo Corporate & Investment Banking Young Li - Jefferies Travis Steed - BofA...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 3,900
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today